This inventor holds 1 USPTO granted patent. Top assignee: Industry Academic Cooperation Foundation Hallym University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Han Na Lee: Innovator in Regenerative Medicine
Introduction
Han Na Lee is a prominent inventor based in Chuncheon-si, South Korea. He has made significant contributions to the field of regenerative medicine through his innovative research and development of advanced materials.
Latest Patents
Han Na Lee holds a patent for a photo-curable bioink designed to fabricate ultra-strong, electroconductive, and biocompatible hydrogels. This invention is particularly relevant for regenerative medicine, as it addresses the need for materials that can mimic the mechanical properties of soft tissues. The patent outlines a comprehensive process that includes the physical or chemical modification of natural polymers, carboxylation of graphene oxide, and three-dimensional bioprinting techniques. This innovative approach results in a hydrogel that exhibits high mechanical strength, making it suitable for applications in load-bearing soft tissues such as tendons and the heart.
Career Highlights
Han Na Lee is affiliated with the Industry Academic Cooperation Foundation at Hallym University. His work has been instrumental in advancing the understanding and application of biocompatible materials in medical settings. His research has garnered attention for its potential to improve patient outcomes in regenerative therapies.
Collaborations
Han Na Lee has collaborated with notable colleagues, including Chan Hum Park and Young Jin Lee. These partnerships have contributed to the successful development and refinement of his innovative technologies.
Conclusion
Han Na Lee's contributions to the field of regenerative medicine through his patented bioink technology highlight his role as a leading inventor. His work not only advances scientific knowledge but also holds promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile